Science and Technology
publicado em 07/11/2011 às 13h54:00
   Dê o seu voto:

Emilio Ribas Hospital tests new hepatitis C drugs in partnership with FDA

For the core team to support the Institute's research, studies in progress promise to revolutionize the treatment of disease

 
font size
A-
A+

Some pieces of information on this page may have been automatically translated. Makernews is not responsible for the irregularities resulting from these translations. When in doubt,      consult the original text.



The state hospital Emilio Ribas, a unit of the State Health Secretariat of São Paulo reference in infectious diseases, has been testing new more powerful drugs for treatment and cure for hepatitis C. The surveys take place in partnership with the FDA, the agency that regulates the sector of food and medicine in the United States.

For the team at the Center for Research Support of the Emilio Ribas Institute, studies in progress promise to revolutionize the treatment of disease. Two synthetic drugs - telaprevir and boceprevir - are already in use in the United States and Europe and have just been approved by ANVISA for sale. The expectation is that drugs are available for public patients to the second half of 2012.

According to Dr. Roberto Focaccia, responsible for studies in the Emilio Ribas, among nine patients who received telaprevir combined with conventional treatment, eight were cured. Efficacy has been shown even in the shorter duration of treatment, decreasing from one year to an average of ten months, he said.

The researchers also hope, someday replace Interferon, a drug with side effects similar to chemotherapy. The intention is to use drugs with fewer side effects.

Source: Isaude.net
   Palavras-chave:   State Hospital Emilio Ribas    Sao Paulo    Infectious diseases    New drugs    Treatment    Cure    Hepatitis C    Partnership    FDA    USA.   
  • Share this pageShare this page
  • Share this pageCorrect
  • ShareShare
  • AlertAlert
Reduced link: 
  • You are recommending this story: Emilio Ribas Hospital tests new hepatitis C drugs in partnership with FDA
  • Fill in the following form to send your recommendation to your friend:

  • You are suggesting a correction for this story: Emilio Ribas Hospital tests new hepatitis C drugs in partnership with FDA


Receba notícias do iSaúde no seu e-mail de acordo com os assuntos de seu interesse.
Seu nome:
Seu email:
Desejo receber um alerta com estes assuntos:
State Hospital Emilio Ribas    Sao Paulo    infectious diseases    new drugs    treatment    cure    hepatitis C    partnership    FDA    USA.   
Comments:
Comment
Leave your comment
Close
(Required fields are marked with an *)

(Your email address will never be published or shared.)

Enter the letters and numbers below and click in the button "send"

  • Twitter iSaúde
advertising
Informe Saúde printed version

Recommend the portal
Close [X]
  • You are recommending this story: http://www.isaude.net
  • Fill in the following form to send your recommendation to your friend:

RSS news from the portal  iSaúde.net
Get the newsletter of the portal  iSaúde.net
Recommend the portal iSaúde.net
News from  iSaúde.net in your blog or website.
Get news on the subject of your interest.
© 2000-2011 www.isaude.net Todos os direitos reservados.